149 related articles for article (PubMed ID: 28713681)
1. The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices.
Chaikh A; Balosso J
Transl Lung Cancer Res; 2017 Jun; 6(3):366-372. PubMed ID: 28713681
[TBL] [Abstract][Full Text] [Related]
2. Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index.
Chaikh A; Balosso J
Transl Lung Cancer Res; 2016 Jun; 5(3):265-71. PubMed ID: 27413708
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
4. Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung cancer treatment: do we need to measure radiotherapy outcomes to tune the radiobiological parameters of a normal tissue complication probability model?
Chaikh A; Docquière N; Bondiau PY; Balosso J
Transl Lung Cancer Res; 2016 Dec; 5(6):673-680. PubMed ID: 28149761
[TBL] [Abstract][Full Text] [Related]
5. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
6. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological impact of planning techniques for prostate cancer in terms of tumor control probability and normal tissue complication probability.
Rana S; Cheng C
Ann Med Health Sci Res; 2014 Mar; 4(2):167-72. PubMed ID: 24761232
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric assessment of tumor control probability in intensity and volumetric modulated radiotherapy plans.
Wang H; Cooper BT; Schiff P; Sanfilippo NJ; Wu SP; Hu KS; Das IJ; Xue J
Br J Radiol; 2019 Feb; 92(1094):20180471. PubMed ID: 30209959
[TBL] [Abstract][Full Text] [Related]
9. Statistic and dosimetric criteria to assess the shift of the prescribed dose for lung radiotherapy plans when integrating point kernel models in medical physics: are we ready?
Chaikh A; Balosso J
Transl Lung Cancer Res; 2016 Dec; 5(6):681-687. PubMed ID: 28149762
[TBL] [Abstract][Full Text] [Related]
10. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
11. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
12. Correlation between pneumonitis risk in radiation oncology and lung density measured with X-ray computed tomography.
Chaikh A; Balosso J
Quant Imaging Med Surg; 2016 Aug; 6(4):413-417. PubMed ID: 27709077
[TBL] [Abstract][Full Text] [Related]
13. Correlation of contouring variation with modeled outcome for conformal non-small cell lung cancer radiotherapy.
Jameson MG; Kumar S; Vinod SK; Metcalfe PE; Holloway LC
Radiother Oncol; 2014 Sep; 112(3):332-6. PubMed ID: 24853367
[TBL] [Abstract][Full Text] [Related]
14. The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.
Zhu J; Simon A; Haigron P; Lafond C; Acosta O; Shu H; Castelli J; Li B; De Crevoisier R
Onco Targets Ther; 2016; 9():7537-7544. PubMed ID: 28003767
[TBL] [Abstract][Full Text] [Related]
15. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
[TBL] [Abstract][Full Text] [Related]
16. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
17. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
[TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison of dose distribution in radiotherapy plans using 2D gamma maps and X-ray computed tomography.
Chaikh A; Balosso J
Quant Imaging Med Surg; 2016 Jun; 6(3):243-9. PubMed ID: 27429908
[TBL] [Abstract][Full Text] [Related]
19. Associating dose-volume characteristics with theoretical radiobiological metrics for rapid Gamma Knife stereotactic radiosurgery plan evaluation.
Tien CJ; Bond JE; Chen ZJ
J Appl Clin Med Phys; 2020 Oct; 21(10):132-140. PubMed ID: 32910543
[TBL] [Abstract][Full Text] [Related]
20. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
